{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:42:03Z","timestamp":1791229323261,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/md.0b013e3182a71eba","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T09:26:50Z","timestamp":1377595610000},"page":"e1-e9","source":"Crossref","is-referenced-by-count":93,"title":["The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia"],"prefix":"10.1097","volume":"92","author":[{"given":"Fanny","family":"Legrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Renneville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"MacIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Mastrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Ackermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Cayuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rousselot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Schmidt-Tanguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Fain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"de Jaureguiberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Hatron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Cony-Makhoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Lefranc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"S\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hamidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lidove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Baruchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Dubucquoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bletry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Preudhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Capron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Prin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Emmanuel","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210309","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3324\/haematol.11420","article-title":"The efficacy of imatinib mesylate in patients with FIP1L1-PDGFR-positive hypereosinophilic syndrome. Results of a multicenter prospective study.","volume":"92","author":"Baccarani","year":"2007","journal-title":"Haematologica"},{"key":"R2-1-20210309","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","article-title":"Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment.","volume":"118","author":"Chu","year":"2011","journal-title":"Blood"},{"key":"R3-1-20210309","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/sj.leu.2404670","article-title":"WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia.","volume":"21","author":"Cilloni","year":"2007","journal-title":"Leukemia"},{"key":"R4-1-20210309","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1200\/JCO.2009.22.4865","article-title":"Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.","volume":"27","author":"Cilloni","year":"2009","journal-title":"J Clin Oncol"},{"key":"R5-1-20210309","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"R6-1-20210309","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"R7-1-20210309","first-page":"17","article-title":"Cell clonality in hypereosinophilic syndrome: what pathogenetic role Clin Exp Rheumatol.","volume":"25","author":"Galimberti","year":"2007","journal-title":""},{"key":"R8-1-20210309","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/leu.2008.287","article-title":"Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias.","volume":"22","author":"Gotlib","year":"2008","journal-title":"Leukemia"},{"key":"R9-1-20210309","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/hon.919","article-title":"Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcriptresults of Polish multicentre study.","volume":"28","author":"Helbig","year":"2010","journal-title":"Hematol Oncol"},{"key":"R10-1-20210309","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2141.2008.07546.x","article-title":"Weekly imatinib dosage for chronic eosinophilic leukaemia expressing FIP1L1-PDGFRA fusion transcript: extended follow-up.","volume":"145","author":"Helbig","year":"2009","journal-title":"Br J Haematol"},{"key":"R11-1-20210309","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2141.2008.07033.x","article-title":"A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients.","volume":"141","author":"Helbig","year":"2008","journal-title":"Br J Haematol"},{"key":"R12-1-20210309","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood.V89.4.1405","article-title":"Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia.","volume":"89","author":"Inoue","year":"1997","journal-title":"Blood"},{"key":"R13-1-20210309","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1182\/blood-2006-10-050054","article-title":"Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia.","volume":"109","author":"Jovanovic","year":"2007","journal-title":"Blood"},{"key":"R14-1-20210309","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","article-title":"Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness.","volume":"101","author":"Klion","year":"2003","journal-title":"Blood"},{"key":"R15-1-20210309","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1182\/blood-2007-07-100164","article-title":"Relapse following discontinuation of imatinib mesylate therapy for FIP1L1PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing.","volume":"110","author":"Klion","year":"2007","journal-title":"Blood"},{"key":"R16-1-20210309","first-page":"253","article-title":"Prognostic factors of hypereosinophilic syndrome. Study of 40 cases.","volume":"140","author":"Lefebvre","year":"1989","journal-title":"Ann Med Interne (Paris)"},{"key":"R17-1-20210309","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial.","volume":"11","author":"Mahon","year":"2010","journal-title":"Lancet Oncol"},{"key":"R18-1-20210309","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2007.05.024","article-title":"KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1PDGFRA-associated chronic eosinophilic leukemia are distinct entities.","volume":"120","author":"Maric","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R19-1-20210309","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2141.1998.00701.x","article-title":"Distinction of eosinophilic leukaemia from idiopathic hypereosinophilic syndrome by analysis of Wilms tumour gene expression.","volume":"101","author":"Menssen","year":"1998","journal-title":"Br J Haematol"},{"key":"R20-1-20210309","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R21-1-20210309","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1182\/blood-2004-03-0787","article-title":"FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia.","volume":"104","author":"Pardanani","year":"2004","journal-title":"Blood"},{"key":"R22-1-20210309","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2002-10-3103","article-title":"Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders.","volume":"101","author":"Pardanani","year":"2003","journal-title":"Blood"},{"key":"R23-1-20210309","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1182\/blood-2003-07-2393","article-title":"Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes.","volume":"102","author":"Pitini","year":"2003","journal-title":"Blood"},{"key":"R24-1-20210309","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/pbc.22655","article-title":"Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate.","volume":"55","author":"Rathe","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R25-1-20210309","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/01.mph.0000193467.06938.77","article-title":"Idiopathic hypereosinophilic syndrome in children: report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement.","volume":"27","author":"Rives","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"R26-1-20210309","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.leu.2403722","article-title":"Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics.","volume":"19","author":"Roche-Lestienne","year":"2005","journal-title":"Leukemia"},{"key":"R27-1-20210309","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.","volume":"130","author":"Valent","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R28-1-20210309","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.leu.2403313","article-title":"Clinical and molecular features of FIP1L1-PDFGRA () chronic eosinophilic leukemias.","volume":"18","author":"Vandenberghe","year":"2004","journal-title":"Leukemia"},{"key":"R29-1-20210309","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"R30-1-20210309","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","article-title":"The idiopathic hypereosinophilic syndrome.","volume":"83","author":"Weller","year":"1994","journal-title":"Blood"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0b013e3182a71eba","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T08:32:30Z","timestamp":1715934750000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201309000-00001"}},"subtitle":["New Insights Based on a Survey of 44 Cases"],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3182a71eba","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}